When it comes to the latest blockbuster medications in the world of weight loss and diabetes management, two names dominate the conversation: Tirzepatide (Zepbound/Mounjaro) and Semaglutide (Ozempic/Wegovy)
Tirzepatide and semaglutide are both medications that target weight loss and blood sugar control, but they differ in their mechanisms of action and formulations
That is normal in obesity and diabetes treatment, and it is one reason dose titration and medical review matter
If you have ADHD and are concerned about misuse risk, talk with your healthcare provider about monitoring, dosing strategies, and non-stimulant options
We observed that 11.8% of tirzepatide-treated rs1800437-CC carrier individuals experienced vomiting, compared with 9.4% for semaglutide-treated people carrying the same genotype, although the difference was not significant ( P = 0.12, two-sample z -test
Stop by Brews & Blends This Week Come see us and ask about our fiber options